Wang et al. reported that γ-mangostin attenuated liver fibrosis by inhibiting NAD(P)H oxidase activity through SIRT3 enhancement, resulting in reduced intracellular oxidative stress [49]. This evidence concerns the gene SIRT3 and Hepatic fibrosis.